NRGSX
Price
$62.63
Change
+$0.26 (+0.42%)
Updated
Aug 21 closing price
Net Assets
7.39B
PQSAX
Price
$24.95
Change
+$0.21 (+0.85%)
Updated
Aug 21 closing price
Net Assets
566.94M
Interact to see
Advertisement

NRGSX vs PQSAX

NRGSX vs PQSAX Comparison Chart in %
View a ticker or compare two or three
VS
NRGSX vs. PQSAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRGSX is a Buy and PQSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 7.39B vs. PQSAX (567M). NRGSX pays higher dividends than PQSAX: NRGSX (0.45) vs PQSAX (0.27). NRGSX was incepted earlier than PQSAX: NRGSX (13 years) vs PQSAX (20 years). PQSAX (1.22) is less costly to investors than NRGSX (0.74). NRGSX is a more actively managed with annual turnover of: 23.00 vs. PQSAX (12.00). NRGSX has a lower initial minimum investment than PQSAX: NRGSX (0) vs PQSAX (2500). NRGSX annual gain was more profitable for investors over the last year : -1.20 vs. PQSAX (-2.11). PQSAX return over 5 years is better than : -6.58 vs. NRGSX (-18.93).
NRGSXPQSAXNRGSX / PQSAX
Total Expense Ratio0.741.2261%
Annual Report Gross Expense Ratio0.741.2261%
Fund Existence13 years20 years-
Gain YTD16.5438.762189%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets7.39B567M1,303%
Annual Yield % from dividends0.450.27167%
Returns for 1 year-1.20-2.1157%
Returns for 3 years7.1413.2554%
Returns for 5 years-18.93-6.58288%
Returns for 10 years12.8666.6419%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIHS1.460.11
+8.15%
Senmiao Technology Limited
IPHA2.260.17
+8.13%
Innate Pharma SA
PRCT21.680.95
+4.58%
PROCEPT BioRobotics Corp
KKR108.481.46
+1.36%
KKR & Co
NICE100.24-0.13
-0.13%
NICE Ltd